ArticleJournal of pharmaceutical policy and practice2015
Pharmaceutical policy Part 1 The challenge to pharmacists to engage in policy development.
Article in Journal of pharmaceutical policy and practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 18 citations in OpenAlex.
- Beyond descriptive SWOT in pharmacy strategy: A quantitative framework for leaders, managers and educators from prioritization to strategic response.Exploratory research in clinical and social pharmacy · 2026Article
- Young pharmacists as tomorrow's decision-makers: tool validation and perceptions of pharmaceutical policymaking in Lebanon.Journal of pharmaceutical policy and practice · 2026Article
- An exploratory study of the mandate and functions of national pharmaceutical services units: global trends and the cases of Côte d'Ivoire, Kenya, and Nepal.Journal of pharmaceutical policy and practice · 2024Article
- Access to Medicines and Pharmaceutical Policy in Saudi Arabia: A Scoping Review.Integrated pharmacy research & practice · 2023Article
- Performance of a pharmaceutical services regionalization strategy policy in Minas Gerais, Brazil: Pre-post analysis from ERAF project.Frontiers in pharmacology · 2022Article
- National pharmacy associations in the commonwealth: current scenario and future needs to maximise effective contributions of the pharmacy profession towards universal health coverage.Journal of pharmaceutical policy and practice · 2021Article
- Novel models to improve access to medicines for chronic diseases in South Africa: an analysis of stakeholder perspectives on community-based distribution models.Journal of pharmaceutical policy and practice · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Across the world medicines are the ubiquitous technology in the diagnosis, treatment and prevention of disease. Pharmaceutical policy, as part of national health care policy, is concerned with the provision and use of medicines. Pharmacists are critical to the medicines management process, yet are often largely detached from policy development. Logically, they should inform Government policies which impact on their work or where their skills could be best applied to implement health care policy and medicines utilisation in particular. It therefore makes it critically important that the pharmaceutical profession engages with national policy makers and in the strategic planning for health care. This is the first of two articles directed to this specific issue. Firstly, it identifies a number of the practice challenges for pharmacy and medicines management, their implications for policy and the need for a balanced approach. Drawing from a range of international experiences some key learning points in respect of formulating and implementing national medicines policies are presented. Finally, reference is made to several authoritative evidence bases to inform the development of pharmaceutical practice and medicines management policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.